Latest news
Biotechnology Stocks To Watch As Investors Look Past Pfizer’s Covid Revenue Drop - simplywall.stsimplywall.st · Sun, 09 Aug 2026 02:46:08 GMTPfizer (NYSE:PFE) climbs 7% after main drugs offset fall in COVID sales - TechStock²TechStock² · Sat, 08 Aug 2026 20:43:30 GMTPfizer (NYSE:PFE) Shares Gain as Four Major Drugs Compensate for COVID Revenue Hit - TechStock²TechStock² · Wed, 05 Aug 2026 13:59:37 GMTPfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway. - Barron'sBarron's · Tue, 04 Aug 2026 21:27:00 GMTPfizer lifts revenue outlook as non-COVID portfolio offsets sales decline - The Pharma LetterThe Pharma Letter · Tue, 04 Aug 2026 14:40:35 GMTPfizer Tops Q2 Estimates as Main Drug Revenue Balances Drop in COVID Sales - TechStock²TechStock² · Tue, 04 Aug 2026 12:30:27 GMTGermany's BioNTech Q2 revenue drops 60% on lower COVID-19 vaccine demand - TradingViewTradingView · Tue, 04 Aug 2026 11:08:08 GMT